First reported case of intraventricular tigecycline for meningitis from extremely drug-resistant Acinetobacter baumannii

Liverana Lauretti, Quintino Giorgio D'Alessandris*, Massimo Fantoni, Tiziana D'Inzeo, Eduardo Fernandez, Roberto Pallini, Giancarlo Scoppettuolo

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaArticolo

20 Citazioni (Scopus)

Abstract

The authors report on the first case of the intraventricular administration of tigecycline described in the Western literature. A 22-year-old man developed cerebrospinal fluid infection from an extremely drug-resistant strain of Acinetobacter baumannii as a complication of endoscopic transsphenoidal surgery for the removal of a giant pituitary adenoma. The patient was safely and successfully treated with the prolonged intraventricular administration of tigecycline. Here, the authors provide the schedule details that can be invaluable in treating meningitis from extremely drug-resistant bacterial strains. Intraventricular tigecycline can be a valuable tool against multidrug-resistant central nervous system infections.
Lingua originaleInglese
pagine (da-a)370-373
Numero di pagine4
RivistaJournal of Neurosurgery
Volume127
Numero di pubblicazione2
DOI
Stato di pubblicazionePubblicato - 2017

All Science Journal Classification (ASJC) codes

  • Chirurgia
  • Neurologia (clinica)

Keywords

  • Acinetobacter
  • CNS = central nervous system
  • CSF = cerebrospinal fluid
  • IV = intravenous
  • IVT = intraventricular
  • MDR = multidrug resistant
  • XDR = extremely drug resistant
  • infection
  • intraventricular therapy
  • meningitis
  • tigecycline
  • transsphenoidal surgery

Fingerprint

Entra nei temi di ricerca di 'First reported case of intraventricular tigecycline for meningitis from extremely drug-resistant Acinetobacter baumannii'. Insieme formano una fingerprint unica.

Cita questo